Insider Buying: Cerecor Inc (CERC) Major Shareholder Purchases 36,400 Shares of Stock

Share on StockTwits

Cerecor Inc (NASDAQ:CERC) major shareholder Armistice Capital Master Fund bought 36,400 shares of the firm’s stock in a transaction that occurred on Monday, December 10th. The stock was purchased at an average cost of $3.41 per share, with a total value of $124,124.00. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Large shareholders that own more than 10% of a company’s shares are required to disclose their transactions with the SEC.

Armistice Capital Master Fund also recently made the following trade(s):

  • On Tuesday, December 4th, Armistice Capital Master Fund bought 25,797 shares of Cerecor stock. The stock was purchased at an average cost of $3.49 per share, with a total value of $90,031.53.
  • On Thursday, November 29th, Armistice Capital Master Fund bought 77,803 shares of Cerecor stock. The stock was purchased at an average cost of $3.51 per share, with a total value of $273,088.53.
  • On Monday, November 26th, Armistice Capital Master Fund bought 50,000 shares of Cerecor stock. The stock was purchased at an average cost of $3.59 per share, with a total value of $179,500.00.
  • On Tuesday, November 20th, Armistice Capital Master Fund acquired 49,100 shares of Cerecor stock. The shares were bought at an average cost of $3.61 per share, with a total value of $177,251.00.
  • On Thursday, November 15th, Armistice Capital Master Fund acquired 31,314 shares of Cerecor stock. The shares were bought at an average cost of $3.85 per share, with a total value of $120,558.90.
  • On Wednesday, October 31st, Armistice Capital Master Fund acquired 5,986 shares of Cerecor stock. The shares were bought at an average cost of $3.92 per share, with a total value of $23,465.12.
  • On Monday, October 29th, Armistice Capital Master Fund acquired 107,800 shares of Cerecor stock. The shares were bought at an average cost of $3.95 per share, with a total value of $425,810.00.
  • On Wednesday, October 24th, Armistice Capital Master Fund acquired 125,800 shares of Cerecor stock. The shares were bought at an average cost of $4.13 per share, with a total value of $519,554.00.
  • On Tuesday, October 9th, Armistice Capital Master Fund acquired 29,600 shares of Cerecor stock. The shares were bought at an average cost of $4.34 per share, with a total value of $128,464.00.
  • On Thursday, September 27th, Armistice Capital Master Fund acquired 20,400 shares of Cerecor stock. The shares were bought at an average cost of $4.64 per share, with a total value of $94,656.00.

CERC stock opened at $3.36 on Wednesday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.74 and a quick ratio of 0.70. Cerecor Inc has a one year low of $1.74 and a one year high of $5.74. The firm has a market cap of $138.33 million, a price-to-earnings ratio of 8.00 and a beta of 1.42.

A number of hedge funds have recently added to or reduced their stakes in the business. Spark Investment Management LLC acquired a new stake in shares of Cerecor during the second quarter worth $288,000. Cambridge Investment Research Advisors Inc. acquired a new stake in shares of Cerecor during the third quarter worth $169,000. Finally, BlackRock Inc. lifted its holdings in shares of Cerecor by 630.4% during the second quarter. BlackRock Inc. now owns 27,520 shares of the company’s stock worth $120,000 after buying an additional 23,752 shares in the last quarter. 44.48% of the stock is owned by hedge funds and other institutional investors.

A number of equities analysts have commented on the stock. ValuEngine raised shares of Cerecor from a “hold” rating to a “buy” rating in a research report on Thursday, August 23rd. TheStreet raised shares of Cerecor from a “d” rating to a “c” rating in a research report on Monday, November 12th.

TRADEMARK VIOLATION WARNING: “Insider Buying: Cerecor Inc (CERC) Major Shareholder Purchases 36,400 Shares of Stock” was originally posted by Equities Focus and is the sole property of of Equities Focus. If you are accessing this piece on another publication, it was illegally copied and republished in violation of U.S. and international trademark & copyright law. The legal version of this piece can be viewed at https://www.equitiesfocus.com/2018/12/12/insider-buying-cerecor-inc-cerc-major-shareholder-purchases-36400-shares-of-stock.html.

Cerecor Company Profile

Cerecor Inc, a pharmaceutical company, focuses on pediatric health care. Its lead product portfolio includes prescribed dietary supplements, such as Poly-Vi-Flor and Tri-Vi-Flor; and prescription drugs, such as Millipre, Veripred, and Ulesfia for the treatment of inflammation of the skin, joints, lungs, and other organs, as well as asthma, allergies, arthritis, and head lice infestation.

Featured Story: Balance Sheet

Insider Buying and Selling by Quarter for Cerecor (NASDAQ:CERC)

Receive News & Ratings for Cerecor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerecor and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply